Center for Biologics Evaluation and Research (U.S.) & Center for Drug Evaluation and Research (U.S.). (2006). Guidance for industry: Biological product deviation reporting for licensed manufacturers of biological products other than blood and blood components. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Biologics Evaluation and Research (U.S.) and Center for Drug Evaluation and Research (U.S.). Guidance for Industry: Biological Product Deviation Reporting for Licensed Manufacturers of Biological Products Other than Blood and Blood Components. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, 2006.
MLA (9th ed.) CitationCenter for Biologics Evaluation and Research (U.S.) and Center for Drug Evaluation and Research (U.S.). Guidance for Industry: Biological Product Deviation Reporting for Licensed Manufacturers of Biological Products Other than Blood and Blood Components. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, 2006.